Arabi Saeed, Vardell Victoria, Hanley Timothy, Florell Scott, Halwani Ahmad, Lim Ming
Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Case Rep Hematol. 2025 May 23;2025:8582804. doi: 10.1155/crh/8582804. eCollection 2025.
Primary cutaneous gamma-delta T-cell lymphoma (PCGD-TCL) is a very rare subtype of cutaneous T-cell lymphoma. We report the case of a young Polynesian male who presented with fever and an abdominal wall rash and highlight the workup leading to the diagnosis of PCGD-TCL. As PCGD-TCL is rare and mimics other medical conditions, its diagnosis requires a high index of suspicion and can be challenging. Hemophagocytic lymphohistiocytosis (HLH) occurs with PCGD-TCL and can be a marker of more invasive disease. There are no well-defined treatment guidelines, but the most common treatment approach is anthracycline-based multiagent chemotherapy followed by allogeneic stem cell transplant. Targeted therapies are being increasingly used as well. Prognosis remains poor and 5-year survival is < 20%, particularly in more invasive disease. We highlight how this patient's demographic varies from the published literature and discuss some unique particulars of the diagnostic evaluation and treatment, especially in the presence of concurrent HLH.
原发性皮肤γ-δ T细胞淋巴瘤(PCGD-TCL)是皮肤T细胞淋巴瘤中一种非常罕见的亚型。我们报告了一例年轻的波利尼西亚男性病例,该患者出现发热和腹壁皮疹,并着重介绍了最终诊断为PCGD-TCL的检查过程。由于PCGD-TCL较为罕见且可模仿其他病症,其诊断需要高度的怀疑指数,且具有挑战性。噬血细胞性淋巴组织细胞增生症(HLH)与PCGD-TCL同时出现,可能是疾病更具侵袭性的一个标志。目前尚无明确的治疗指南,但最常见的治疗方法是基于蒽环类药物的多药化疗,随后进行异基因干细胞移植。靶向治疗的应用也越来越多。预后仍然很差,5年生存率<20%,尤其是在疾病更具侵袭性的情况下。我们强调了该患者的人口统计学特征与已发表文献的差异,并讨论了诊断评估和治疗的一些独特细节,特别是在合并HLH的情况下。